EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Axol Bioscience Appoints Chief Scientific Officer

The stem cell disease model specialists recruit leading biologist, Prof Xianmin Zeng as Chief Scientific Officer   Cambridge, UK, 12 January 2016: Axol Bioscienc...
Continue Reading →
Europe

Novartis sale of Suffern, NY, facility likely to finalize this winter

After almost two years on the auction block, Novartis' ($NVS) manufacturing facility in Suffern, NY, is likely to be sold by the end of this winter as two developers...
Continue Reading →
Asia Pacific

Teva, Takeda add details on new venture in Japan

The independent company being created by a joint venture between Israel's Teva Pharmaceutical Industries ($TEVA) and Japan's Takeda Pharmaceutical became a bit more c...
Continue Reading →
Europe

Exco InTouch announces the demonstration of equivalence for EQ-5D-5L

ScHARR completes independent, scientific, peer reviewed study, funded by Exco InTouch, comparing EQ-5D-5L equivalence across mobile phone and paper administration mod...
Continue Reading →
news

A New Approach to Revolutionize Clinical Trials

It may be the biggest thing in medicine in a long time. It's not a new drug, or therapy or discovery. Instead it's a new way of doing clinical trials which could have...
Continue Reading →
news

Antidepressant with novel action appears safe, effective in clinical trial

December 8, 2015 - A small clinical trial of a novel antidepressant that stimulates neurogenesis -- the production of new brain cells -- shows that the compound appea...
Continue Reading →
news

Aduro Biotech Says All Clinical Trials Will Continue Unaltered and as Planned

Aduro Biotech (ADRO), a clinical-stage immunotherapy company, confirmed late Tuesday that it will continue all its clinical trials unaltered and as planned. The annou...
Continue Reading →
news

Clinical trial could lead to new bladder cancer drug

A bladder cancer drug tested in a University of Hawai'i Cancer Center clinical trial is getting closer to Food and Drug Administration (FDA) approval. The new drug, ...
Continue Reading →
news

Otonomy Initiates Phase 1 Clinical Trial for Tinnitus Product Candidate, OTO-311

SAN DIEGO, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization ...
Continue Reading →
news

Clinical Trial Data Underreported: Study

One-third of the human experiments for approved drugs failed transparency requirements. Volunteers for clinical trials shouldn’t get their hopes up too high that dat...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Pharmap: Wed 13 November 2024, 10:36
Biosynth: Wed 13 November 2024, 10:18